EC Ophthalmology

Case Report Volume 17 Issue 1 - 2026

Bilateral Optic Pathway Glioma in a Pediatric Patient with Neurofibromatosis Type 1: A Case Report

Pablo Tejada González*, Cristina Calvo Simón, Javier Ascaso Puyuelo, Diana Pérez García, Juana Martínez Morales, Inmaculada Herrero Sánchez, Edurne de la Cámara Sahuquillo and Juan Ibáñez Alperte

Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain

*Corresponding Author: Pablo Tejada González, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
Received: December 08, 2025; Published: December 30, 2025



Purpose: To describe a case of bilateral optic pathway gliomas (OPG) in a pediatric patient with neurofibromatosis type 1 (NF1), highlighting multimodal ophthalmic findings, radiologic correlation, and considerations for clinical management.

Case Presentation: A 4-year-old girl with recently diagnosed NF1 was referred for ophthalmologic evaluation. Best-corrected visual acuity (BCVA) was 20/40 in both eyes. Pupils were symmetric without relative afferent pupillary defect. Anterior segment examination revealed Lisch nodules, and dilated fundus evaluation showed mild bilateral optic disc pallor. Optical coherence tomography (OCT) demonstrated sectoral thinning of the circumpapillary retinal nerve fiber layer (RNFL), predominantly temporally and nasally. Due to progressive BCVA decline in subsequent visits and structural worsening on OCT, brain and orbital MRI were obtained, revealing fusiform enlargement of both optic nerves extending toward the chiasm, consistent with bilateral optic pathway gliomas. Given progressive visual involvement, the patient was referred to pediatric oncology and treated with weekly vinblastine.

Conclusion: Bilateral OPGs are a recognized manifestation of NF1. Progressive visual decline and OCT/RNFL thinning should prompt neuroimaging and multidisciplinary evaluation. Early recognition and monitoring are crucial to prevent irreversible vision loss.

 Keywords: Neurofibromatosis Type 1; Optic Pathway Glioma; Pediatric Neuro-Oncology; Retinal Nerve Fiber Layer; Lisch nodules

  1. Friedman JM. “Neurofibromatosis 1”. In: Adam MP, Mirzaa GM, et al. editors. GeneReviews®. University of Washington (2022).
  2. Fisher MJ., et al. “Functional outcomes in children with NF1-associated optic pathway glioma”. Child's Nervous System 36 (2020): 2591-2603.
  3. Avery RA., et al. “Optic pathway gliomas in NF1: advances in diagnosis and management”. JAMA Ophthalmology12 (2020): 1311-1319.
  4. Guillamo JS., et al. “Prognostic factors of NF1-associated optic pathway gliomas: a retrospective study”. Brain 144 (2021): 1500-1512.
  5. Balcer LJ., et al. “Vision loss in children with NF1-related OPG correlates with RNFL thinning”. Ophthalmology 7 (2021): 1023-1032.
  6. Bouffet E., et al. “Vinblastine for pediatric low-grade gliomas: long-term outcomes”. Neuro-Oncology 12 (2020): 1789-1798.
  7. Gross AM., et al. “Selumetinib in children with NF1-associated tumors”. New England Journal of Medicine 15 (2020): 1430-1442.

Pablo Tejada González., et al. “Bilateral Optic Pathway Glioma in a Pediatric Patient with Neurofibromatosis Type 1: A Case Report”. EC Ophthalmology  17.1 (2026): 01-05.